Personal profile
Fields of Science
- 3122 Cancers
- 1182 Biochemistry, cell and molecular biology
Collaborations and top research areas from the last five years
-
Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real-World Data
Pignatti, F., El-Galaly, T. C., Kaiser, M., Porkka, K., Doeswijk, R., Mol, P., Rivera, D. R., Lerro, C. C., Rohr, U. P., Verpillat, P., Valachis, A., Trapani, D., Di Maio, M., Latino, N., Cordoba, R., Cherny, N., Koopman, M., Martins-Branco, D., Pentheroudakis, G. & Postmus, D., 11 Feb 2026, In: Clinical Pharmacology and Therapeutics. 8 p., PMID 372741.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access -
Comorbidities, medication use, and overall survival in eight cancers: a multinational cohort study of 1.7 million patients across Europe
López-Sánchez, I., Palomar-Cros, A., Claire, R., Pérez-Crespo, L., Giuliodori, A., Koblbauer, I., Dietz, J., Elvidge, J., Koh, J., Golozar, A., Ramirez-Anguita, J. M., Leis, A., Mayer, M. A., Symmers, N., Vallet, M., McLean, C., Hall, P. S., Mosseveld, M., Verhamme, K. & Enerly, E. & 26 others, , Apr 2026, In: The Lancet Regional Health - Europe. 63, 15 p., 101585.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Novel therapies in myeloid neoplasms show limited benefit and increased costs over 15 years of follow-up in Southern Finland
Lanamtieng, T., Mervaala-Muroke, A., Toivanen, L., Porkka, K. & Brück, O., 6 Feb 2026, In: Annals of Hematology. 105, 3, 11 p., 94.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
A Machine Learning-Based Strategy Predicts Selective and Synergistic Drug Combinations for Relapsed Acute Myeloid Leukemia
Chen, Y., He, L., Ianevski, A., Nader, K., Ruokoranta, T., Linnavirta, N., Miettinen, J. J., Vähä-Koskela, M., Vänttinen, I., Kuusanmäki, H., Kontro, M., Porkka, K., Wennerberg, K., Heckman, C. A., Giri, A. K. & Aittokallio, T., 15 Jul 2025, In: Cancer Research. 85, 14, p. 2753-2768 16 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Computational measurable residual disease assessment in acute myeloid leukemia: a retrospective validation in the HOVON-SAKK-132 trial MINIMAL RESIDUAL DISEASE
Mocking, T. R., Haaksma, L. H., Reuvekamp, T., Kelder, A., Scholten, W. J., Ngai, L. L., Breems, D. A., Fischer, T., Gjertsen, B. T., Griskevicius, L., Juliusson, G., Maertens, J. A., Manz, M. G., Pabst, T., Passweg, J. R., Porkka, K., Valk, P. J. M., Gradowska, P., Lowenberg, B. & de Leeuw, D. C. & 5 others, , Oct 2025, In: Leukemia. 39, 10, p. 2559-2562 4 p.Research output: Contribution to journal › Letter › Scientific
Open AccessFile
-
Syöpäsäätiö 2024-2026 / Porkka
Porkka, K. (Project manager) & Ryzhenkov, A. (Participant)
Syöpäsäätiö sr Cancerstiftelsen sr
01/01/2024 → 31/12/2026
Project: Foundations (Private Foundations, Non-Profit Foundations, Charitable Trusts)
-
Yksilöllisen syöpähoidon professuuri
Olkkola, K. (Project manager) & Porkka, K. (Participant)
Roche Oy, Bayer Oy, Novartis Finland Oy
01/12/2021 → 31/12/2029
Project: Corporate funding
-
Studies of axitinib and axitinib drug combinations as BCR-ABL1 T315I -selective therapies for use in drug-resistant CML and Ph+ ALL
Wennerberg, K. (Project manager), Repasky, G. (Participant), Pemovska, T. (Participant) & Porkka, K. (Project manager)
01/11/2013 → …
Project: Research project
-
Role of polysialic acid in human neuroblastoma
Finne, J. (Project manager), Vettenranta, K. (Participant), Sariola, H. (Participant), Porkka, K. (Participant) & Lehti, T. (Participant)
Project: Research project
Activities
- 1 Other
-
Patient-researcher meetup, hematological cancers
Liljeström, M. (Participant), Mustjoki, S. (Participant), Kontro, M. (Participant), Heckman, C. (Participant), Porkka, K. (Participant), Klievink, J. (Participant), Decombis, S. (Participant), Miettinen, J. (Participant), De Lorenzo, F. (Participant) & Suvela, M. (Participant)
9 Sept 2024Activity: Other activity types › Other